137 related articles for article (PubMed ID: 12810833)
1. Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer.
Ishida H; Murata N; Tada M; Okada N; Hashimoto D; Kubota S; Shirakawa K; Wakasugi H
Jpn J Clin Oncol; 2003 Apr; 33(4):186-91. PubMed ID: 12810833
[TBL] [Abstract][Full Text] [Related]
2. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoembryonic antigen (CEA) levels of peripheral and portal blood and tumor histopathology in colorectal cancer].
Tabuchi Y; Deguchi H; Imanishi K; Saitoh Y
Nihon Geka Gakkai Zasshi; 1986 Dec; 87(12):1540-7. PubMed ID: 3807878
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer.
Okada N; Ishida H; Murata N; Hashimoto D; Seyama Y; Kubota S
Biochem Biophys Res Commun; 2001 Oct; 288(1):212-6. PubMed ID: 11594775
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
6. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
[TBL] [Abstract][Full Text] [Related]
7. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables.
Tabuchi Y; Deguchi H; Imanishi K; Saitoh Y
Cancer; 1987 Apr; 59(7):1283-8. PubMed ID: 3815304
[TBL] [Abstract][Full Text] [Related]
8. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
[TBL] [Abstract][Full Text] [Related]
9. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
10. Quantification of telomerase activity in sporadic colorectal carcinoma: association with tumor growth and venous invasion.
Shoji Y; Yoshinaga K; Inoue A; Iwasaki A; Sugihara K
Cancer; 2000 Mar; 88(6):1304-9. PubMed ID: 10717610
[TBL] [Abstract][Full Text] [Related]
11. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
[TBL] [Abstract][Full Text] [Related]
13. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Zhang W; Yang HC; Wang Q; Yang ZJ; Chen H; Wang SM; Pan ZM; Tang BJ; Li QQ; Li L
Anticancer Res; 2011 Oct; 31(10):3423-8. PubMed ID: 21965756
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer.
Kosaka Y; Mimori K; Fukagawa T; Ishikawa K; Etoh T; Katai H; Sano T; Watanabe M; Sasako M; Mori M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S430-7. PubMed ID: 21761103
[TBL] [Abstract][Full Text] [Related]
17. Macroscopic features at the deepest site of tumor penetration predicting liver metastases of colorectal cancer.
Inomata M; Ochiai A; Sugihara K; Moriya Y; Yamaguchi N; Adachi Y; Kitano S; Hirohashi S
Jpn J Clin Oncol; 1998 Feb; 28(2):123-8. PubMed ID: 9544828
[TBL] [Abstract][Full Text] [Related]
18. The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
Hu S; Zou Z; Li H; Zou G; Li Z; Xu J; Wang L; Du X
PLoS One; 2016; 11(6):e0157486. PubMed ID: 27355390
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and pathological analysis of patients with hepatic metastases from colorectal cancer].
Zhou Z; Zhao G; Wang Y
Zhonghua Wai Ke Za Zhi; 1995 Aug; 33(8):454-7. PubMed ID: 8706556
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Yamada T; Oshima T; Yoshihara K; Tamura S; Kanazawa A; Inagaki D; Yamamoto N; Sato T; Fujii S; Numata K; Kunisaki C; Shiozawa M; Morinaga S; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Anticancer Res; 2010 Jul; 30(7):2693-9. PubMed ID: 20683000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
